Levobunolol compared with timolol: a four-year study.
Br J Ophthalmol
; 72(12): 892-6, 1988 Dec.
Article
en En
| MEDLINE
| ID: mdl-3067745
ABSTRACT
Fifty-one patients with raised intraocular pressure (IOP) were treated for up to four years with one of three ophthalmic solutions 0.5% levobunolol, 1% levobunolol, or 0.5% timolol. The study was conducted as a double-masked, randomised trial in which medications were administered twice daily to both eyes. Levobunolol and timolol were equally effective in reducing overall mean IOP; reductions were greater than 8.8 mmHg in all three treatment groups. The study showed levobunolol to be as safe and effective as timolol in the long-term control of raised IOP.
Texto completo:
1
Banco de datos:
MEDLINE
Asunto principal:
Timolol
/
Glaucoma
/
Levobunolol
Tipo de estudio:
Clinical_trials
Límite:
Aged
/
Female
/
Humans
/
Male
/
Middle aged
Idioma:
En
Año:
1988
Tipo del documento:
Article